Novel swine-origin influenza A virus in humans: Another pandemic knocking at the door

Medical Microbiology and Immunology

Volumn 198, Issue 3, 2009, Pages 175-183

  Michaelis, Martin ^a   Doerr, Hans Wilhem ^a   Cinatl Jr , Jindrich ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

H1N1; Pandemic; Swine influenza; Swine origin influenza A (H1N1) virus

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; ACETYLSALICYLIC ACID; AMANTADINE; FLAVONE DERIVATIVE; FLAVONOID; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLUENZA VACCINE; INTERFERON; MACROLIDE; OSELTAMIVIR; POLYPHENOL DERIVATIVE; PROBENECID; RIBAVIRIN; VIRUS RNA; ZANAMIVIR;

DRUG BLOOD LEVEL; DRUG ELIMINATION; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; NONHUMAN; PANDEMIC; PRIORITY JOURNAL; REVIEW; SWINE DISEASE; VIRUS PATHOGENESIS; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; REASSORTANT VIRUSES; SWINE; SWINE DISEASES; VIRULENCE;

EID: 68349085753     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-009-0118-5     Document Type: Review

References (52)

1. M Michaelis HW Doerr J Cinatl Jr 2009 Of chickens and men: avian influenza in humans Curr Mol Med 9 131 151 10.2174/156652409787581565
2. J Cinatl Jr M Michaelis HW Doerr 2007 The threat of avian influenza A (H5N1). Part I: epidemiologic concerns and virulence determinants Med Microbiol Immunol (Berl) 196 181 190 10.1007/s00430-007-0042-5 (Pubitemid 350105921)
3. J Cinatl Jr M Michaelis HW Doerr 2007 The threat of avian influenza a (H5N1): part II: clues to pathogenicity and pathology Med Microbiol Immunol (Berl) 196 191 201 10.1007/s00430-007-0045-2 (Pubitemid 350105923)
4. J Cinatl Jr M Michaelis HW Doerr 2007 The threat of avian influenza A (H5N1). Part III: antiviral therapy Med Microbiol Immunol (Berl) 196 203 212 10.1007/s00430-007-0048-z (Pubitemid 350105926)
5. J Cinatl Jr M Michaelis HW Doerr 2007 The threat of avian influenza A (H5N1). Part IV: development of vaccines Med Microbiol Immunol (Berl) 196 213 225 10.1007/s00430-007-0052-3 (Pubitemid 350105929)
6. T Horimoto Y Kawaoka 2005 Influenza: lessons from past pandemics, warnings from current incidents Nat Rev Microbiol 3 591 600 10.1038/nrmicro1208 (Pubitemid 41052146)
7. L Simonsen MJ Clarke GD Williamson DF Stroup NH Arden LB Schonberger 1997 The impact of influenza epidemics on mortality: introducing a severity index Am J Public Health 87 1944 1950 10.2105/AJPH.87.12.1944
8. WW Thompson DK Shay E Weintraub L Brammer N Cox LJ Anderson K Fukuda 2003 Mortality associated with influenza and respiratory syncytial virus in the United States JAMA 289 179 186 10.1001/jama.289.2.179 (Pubitemid 36068705)
9. H Kothalawala MJ Toussaint E Gruys 2006 An overview of swine influenza Vet Q 28 46 53
10. MF Ducatez RG Webster RJ Webby 2008 Animal influenza epidemiology Vaccine 26 D67 D69 10.1016/j.vaccine.2008.07.064
11. JK Taubenberger DM Morens 2006 1918 Influenza: the mother of all pandemics Emerg Infect Dis 12 15 22
12. E Thacker B Janke 2008 Swine influenza virus: zoonotic potential and vaccination strategies for the control of avian and swine influenzas J Infect Dis 197 S19 S24 10.1086/524988 (Pubitemid 351323691)
13. KP Myers CW Olsen GC Gray 2007 Cases of swine influenza in humans: a review of the literature Clin Infect Dis 44 1084 1088 10.1086/512813 (Pubitemid 46580277)
14. DJ Sencer JD Millar 2006 Reflections on the 1976 swine flu vaccination program Emerg Infect Dis 12 29 33
15. LB Schonberger DJ Bregman JZ Sullivan-Bolyai RA Keenlyside DW Ziegler HF Retailliau DL Eddins JA Bryan 1979 Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977 Am J Epidemiol 110 105 123
16. JS Marks TJ Halpin 1980 Guillain-Barré syndrome in recipients of A/New Jersey influenza vaccine JAMA 243 2490 2494 10.1001/jama.243.24.2490 (Pubitemid 10039238)
17. I Nachamkin SV Shadomy AP Moran N Cox C Fitzgerald H Ung AT Corcoran JK Iskander LB Schonberger RT Chen 2008 Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome J Infect Dis 198 226 233 10.1086/589624 (Pubitemid 352019288)
18. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team (2009) Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans. N Engl J Med [Epub ahead of print]
19. D Butler 2009 Swine flu goes global Nature 458 1082 1083 10.1038/4581082a
20. V Andreasen C Viboud L Simonsen 2008 Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies J Infect Dis 197 2 270 278 10.1086/524065 (Pubitemid 351263447)
21. C Viboud ON Bjørnstad DL Smith L Simonsen MA Miller BT Grenfell 2006 Synchrony, waves, and spatial hierarchies in the spread of influenza Science 312 447 451 10.1126/science.1125237
22. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, Griffin J, Baggaley RF, Jenkins HE, Lyons EJ, Jombart T, Hinsley WR, Grassly NC, Balloux F, Ghani AC, Ferguson NM, Rambaut A, Pybus OG, Lopez-Gatell H, Apluche-Aranda CM, Chapela IB, Zavala EP, Guevara DM, Checchi F, Garcia E, Hugonnet S, Roth C (2009) The WHO rapid pandemic assessment collaboration. Pandemic potential of a strain of influenza A (H1N1): early findings. Science [Epub ahead of print]
23. E Ghedin NA Sengamalay M Shumway J Zaborsky T Feldblyum V Subbu DJ Spiro J Sitz H Koo P Bolotov D Dernovoy T Tatusova Y Bao K St George J Taylor DJ Lipman CM Fraser JK Taubenberger SL Salzberg 2005 Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution Nature 437 1162 1166 10.1038/nature04239 (Pubitemid 41509354)
24. G Neumann Y Kawaoka 2006 Host range restriction and pathogenicity in the context of influenza pandemic Emerg Infect Dis 12 881 886
25. Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu X, Lindstrom S, Gubareva LV, Deyde V, Garten RJ, Harris M, Gerber S, Vagoski S, Smith F, Pascoe N, Martin K, Dufficy D, Ritger K, Conover C, Quinlisk P, Klimov A, Bresee JS, Finelli L (2009) Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med [Epub ahead of print]
26. R Allwinn W Preiser H Rabenau S Buxbaum M Stürmer HW Doerr 2002 Laboratory diagnosis of influenza-virology or serology? Med Microbiol Immunol (Berl) 191 157 160 10.1007/s00430-002-0137-y (Pubitemid 35435758)
27. A Stieneke-Grober M Vey H Angliker E Shaw G Thomas C Roberts HD Klenk W Garten 1992 Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease EMBO J 11 2407 2414
28. R Salomon RG Webster 2009 The influenza virus enigma Cell 136 3 402 410 10.1016/j.cell.2009.01.029
29. G Gabriel B Dauber T Wolff O Planz HD Klenk J Stech 2005 The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host Proc Natl Acad Sci USA 102 18590 18595 10.1073/pnas.0507415102 (Pubitemid 43011270)
30. M Hatta P Gao P Halfmann Y Kawaoka 2001 Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses Science 293 1840 1842 10.1126/science.1062882 (Pubitemid 32845783)
31. Z Li H Chen P Jiao G Deng G Tian Y Li E Hoffmann RG Webster Y Matsuoka K Yu 2005 Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model J Virol 79 12058 12064 10.1128/JVI.79.18.12058-12064.2005 (Pubitemid 41279322)
32. TM Tumpey CF Basler PV Aguilar H Zeng A Solorzano DE Swayne NJ Cox JM Katz JK Taubenberger P Palese A Garcia-Sastre 2005 Characterization of the reconstructed 1918 Spanish influenza pandemic virus Science 310 77 80 10.1126/science.1119392 (Pubitemid 41434537)
33. D Zamarin A Garcia-Sastre X Xiao R Wang P Palese 2005 Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1 PLoS Pathog 1 e4 10.1371/journal.ppat.0010004
34. JR Coleman 2007 The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages Virol J 4 9 10.1186/1743-422X-4-9 (Pubitemid 46169762)
35. J Lessler NG Reich R Brookmeyer TM Perl KE Nelson DA Cummings 2009 Incubation periods of acute respiratory viral infections: a systematic review Lancet Infect Dis 9 291 300 10.1016/S1473-3099(09)70069-6
36. F Carrat E Vergu NM Ferguson M Lemaitre S Cauchemez S Leach AJ Valleron 2008 Time lines of infection and disease in human influenza: a review of volunteer challenge studies Am J Epidemiol 167 775 785 10.1093/aje/kwm375
37. CJ Murray AD Lopez B Chin D Feehan KH Hill 2006 Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-1920 pandemic: a quantitative analysis Lancet 368 2211 2218 10.1016/S0140-6736(06)69895-4 (Pubitemid 44959013)
38. MA Beck J Handy OA Levander 2004 Host nutritional status: the neglected virulence factor Trends Microbiol 12 417 423 10.1016/j.tim.2004.07.007 (Pubitemid 39178593)
39. DM Morens JK Taubenberger AS Fauci 2008 Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness J Infect Dis 198 962 970 10.1086/591708
40. T Hussell E Wissinger J Goulding 2009 Bacterial complications during pandemic influenza infection Future Microbiol 4 269 272 10.2217/fmb.09.3
41. D Miyamoto S Hasegawa N Sriwilaijaroen S Yingsakmongkon H Hiramatsu T Takahashi K Hidari CT Guo Y Sakano T Suzuki Y Suzuki 2008 Clarithromycin inhibits progeny virus production from human influenza virus-infected host cells Biol Pharm Bull 31 217 222 10.1248/bpb.31.217 (Pubitemid 351198393)
42. M Tsurita M Kurokawa M Imakita Y Fukuda Y Watanabe K Shiraki 2001 Early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection J Pharmacol Exp Ther 298 362 368
43. G Brankston L Gitterman Z Hirji C Lemieux M Gardam 2007 Transmission of influenza A in human beings Lancet Infect Dis 7 257 265 10.1016/S1473-3099(07) 70029-4 (Pubitemid 46414066)
44. R Tellier 2006 Review of aerosol transmission of influenza A virus Emerg Infect Dis 12 1657 1662
45. DL Suarez E Spackman DA Senne L Bulaga AC Welsch K Froberg 2003 The effect of various disinfectants on detection of avian influenza virus by real time RT-PCR Avian Dis 47 1091 1095 10.1637/0005-2086-47.s3.1091
46. WHO 2009 Swine influenza: frequently asked questions Wkly Epidemiol Rec 84 149 151
47. Centers for Disease Control, Prevention (CDC) 2008 Update: influenza activity-United States, September 28-November 29, 2008 MMWR Morb Mortal Wkly Rep 57 1329 1332
48. A Moscona 2008 Global transmission of oseltamivir-resistant influenza N Engl J Med 360 953 956 10.1056/NEJMp0900648
49. GA Poland RM Jacobson IG Ovsyannikova 2009 Influenza virus resistance to antiviral agents: a plea for rational use Clin Infect Dis 48 1254 1256 10.1086/598989
50. Centers for Disease Control, Prevention (CDC) 2009 Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009 MMWR Morb Mortal Wkly Rep 58 433 435
51. Y Wattanagoon K Stepniewska N Lindegårdh S Pukrittayakamee U Silachamroon W Piyaphanee T Singtoroj W Hanpithakpong G Davies J Tarning W Pongtavornpinyo C Fukuda P Singhasivanon NP Day NJ White 2009 Pharmacokinetics of high-dose oseltamivir in healthy volunteers Antimicrob Agents Chemother 53 945 952 10.1128/AAC.00588-08
52. M Holodniy SR Penzak TM Straight RT Davey KK Lee MB Goetz DW Raisch F Cunningham ET Lin N Olivo LR Deyton 2008 Pharmacokinetics and tolerability of oseltamivir combined with probenecid Antimicrob Agents Chemother 52 3013 3021 10.1128/AAC.00047-08